Hovione's $35M CDC Flex line links spray drying to tablets, designed to eliminate scale-up under FDA Q13 guidance.
News|Podcasts|April 4, 2023
Drug Solutions Podcast: Drug Packaging and Sustainability Essentials
Author(s)Jill Murphy
Lon Johnson, VP of Sales and Marketing at Colbert Packaging Corporation, discusses the latest drug packaging updates and how companies can become more sustainable with Pharmaceutical Technology editor Jill Murphy.
Advertisement
In this episode of the Drug Solutions podcast, Jill Murphy, Editor, talks to Lon Johnson, VP of Sales and Marketing at Colbert Packaging Corporation, about drug packaging solutions, sustainable options for companies to move towards, EPR laws, and the challenges of transitioning to more renewable packaging options.
Sponsor:
About the Speaker
Lon Johnson began working in the packaging industry in 1981. He joined Colbert in 1998, and was instrumental in shaping its flexographic printing division, with a vision for the future of pharmaceutical packaging. Currently, he oversees Colbert’s sales and marketing, and has been instrumental in developing patient adherence and clean packaging alternatives. Lon is a member of Colbert’s Board of Directors since 2018. Lon enjoys dedicating time to his industry’s professional associations. He served as president of the IOPP Greater Chicago chapter and was a member of the DCAT Board of Directors. He holds a B.S. from Minnesota State University.
About the Drug Solutions Podcast
Pharmaceutical Technology presents the Drug Solutions podcast, where the editors will chat with industry experts from across the pharmaceutical and biopharmaceutical supply chain. Join us as experts share insights into your biggest questions—from the technologies, to strategies, to regulations related to the development and manufacture of drug products.
Listen to this podcast on
Advertisement
Related to this article
This week on PharmTech, Merck diversified its pipeline, USP emphasizes supply chain security, AI systems are examined, and speakers preview their presentations at CPHI Milan and AAPS PharmSci 360.
Capsugel's Bram Baert and Sandrine Picco argue that chasing zero nitrite in pharmaceutical excipients is often impractical and costly. They recommend setting scientifically justified, risk-based limits and consistently staying below them.
Ron Scarboro, Azurity Pharmaceuticals, claims drug reformulation that removes patient barriers must preserve efficacy, urging early cross-functional team alignment.
PharmTech AI Pulse Check episode 2 covers AI data governance, API-gated journals, watermarking limits, and why attribution beats detection in GxP.
The FDA opened an expedited IND pilot, tightened scrutiny of foreign trial data, and finalized a rule recognizing non-animal testing methods. In Europe, the EMA advanced pharmaceutical legislation reform, restricted 2 legacy products, and opened an injectable-iron safety review.
Novartis licenses Abogen's mRNA-encoded T-cell engager for autoimmune disease, raising scale-up questions for mRNA-lipid nanoparticle manufacturing.
Pharma manufacturing spent 90 years learning that producing correct outputs isn't the same as catching your own errors. AI has only learned the first.
Advertisement
Advertisement